Pharmaceutical Executive
More signs of alignment between startups, pharma, and payers.
Leo Grimaldi, MD
Advertisement
Articles by Leo Grimaldi, MD
Pharmaceutical Executive
Pharma companies are increasingly turning to tech enabled behavioral-based interventions to help improve patient outcomes through their diagnosis, treatment, and coordination of care.
Advertisement
Latest Updated Articles
The Shrinking Disconnect in Digital TherapeuticsAugust 1st 2019
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5